LTZ is Innately Driven to Seek Innovation and Bold Solutions for Patients

Rebalancing the immune system and restoring health

About LTZ

LTZ Therapeutics is an immunotherapy-focused global biotech company pursuing innovative therapies in oncology and autoimmune diseases. Pioneering a novel Myeloid Engager Platform that is guided by reverse translational science, emerging disease biology, and leveraging the power of myeloid cell subsets, particularly macrophages, which offer tremendous potential as an effective therapy to improve the lives of patients with the bold aim to one day eliminate cancer.

Strategic Global Footprint

Follow Us
  • Stay ln Touch

    General Inquiries

    Business Development
  • Locations

    Redwood City, USA

    1100 Island Dr., Suite 103, Redwood City, CA, 94065

    Shenzhen, China

    Room 209, Scientific Research Building, Tsinghua Hi-Tech Park, Nanshan District, Shenzhen, 518057

@ 2024 LTZ Therapeutics Inc., All Rights Reserved.

Privacy Policy | Term of Use | Contact Us